Natalizumab differentially affects plasmablasts and B cells in multiple sclerosis
Alexander Cuculiza Henriksen, Cecilie Ammitzbøll, Eva Rosa Petersen, Oskar McWilliam, Finn Sellebjerg, Marina Rode von Essen, Jeppe Romme Christensen
Topics & Concepts
NatalizumabMultiple sclerosisMedicineFlow cytometryCohortImmunologyB cellInternal medicineGastroenterologyAntibodyMultiple Sclerosis Research StudiesImmunotherapy and Immune Responsesvaccines and immunoinformatics approaches